Angina Treatment - Ecptherapy

Any surgical intervention within 6 weeks before ECP treatment.
Cardiac catheterization within 1-2 weeks before ECP treatment.
Uncontrolled arrhythmia or controlled arrhythmias that could interfere with ECP inflation and deflation triggering.
Dual chamber pacemakers where atrial pacing may interfere with ECP inflation timing sequence. This should be addressed prior to treatment.
Aortic insufficiency (regurgitation can prevent diastolic augmentation).
Severe pulmonary disease.
Limiting peripheral vascular disease involving the ileofemoral arteries.
Deep-vein thrombophlebitis (risk of thromboembolus).
Severe hypertension (≥ 180 mm Hg systolic or ≥110 mm Hg diastolic).
Bleeding disorders.
Patients undergoing major anti-coagulation therapy (such as Heparin therapy or Coumadin®1 therapy) with PT > 1.5.
Heart rates less than 35 or greater than 125 beats per minute (BPM). (Patients with these heart rates should be evaluated and treated prior to ECP treatments).
Presence of local infection, vasculitis of the extremities, or abdominal aortic aneurysm.
Pregnant women and women of childbearing age who do not have a negative pregnancy test.
Presence of a burn, open wound, or bone fracture on any limb subject to ECP treatment. The list above is not exhaustive. A physician should be consulted if in doubt.